Interleukin-6 receptor blockade leads to low fibrinogen values as part of their effects on the acute phase

Research output: Contribution to journal › Letter › Contributed › peer-review

Contributors

Martin Achleitner - , Department of Internal Medicine III, University Center for Autoimmune and Rheumatic Diseases (UCARE) (Author)
Oliver Tiebel - , Institute of Clinical Chemistry and Laboratory Medicine (Author)
Nicolai Leuchten - , Department of Internal Medicine III, University Center for Autoimmune and Rheumatic Diseases (UCARE) (Author)
Martin Aringer - , Department of Internal Medicine III, University Center for Autoimmune and Rheumatic Diseases (UCARE) (Author)